Skip Navigation
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer

Association List

[Full Text]
Displaying Investigations 1 to 36 of 36 found
From 10 References


Brastianos et al 2013, Nat Genet
  Meningioma Brain
FCRL4/IQGAP3
t(1;1)(q23;q23)

Egan et al 2014, PLoS One
  Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma Soft tissue
UHMK1/DDR2
t(1;1)(q23;q23)

Frattini et al 2013, Nat Genet
  Astrocytoma, grade III-IV/Glioblastoma Brain
BCAN/NTRK1
t(1;1)(q23;q23)

Hu et al 2018, Nucleic Acids Res
  Mesenchymal tumor, NOS Unknown site
ARHGEF11/CD48
t(1;1)(q23;q23)
  Malignant melanoma Skin
DCAF8/ETV3
t(1;1)(q23;q23)
  Transitional cell carcinoma Bladder
DCAF8/FCRLA
t(1;1)(q23;q23)
  Squamous cell carcinoma Uterus, cervix
F11R/USF1
t(1;1)(q23;q23)
  Malignant melanoma Skin
KIRREL/DDR2
t(1;1)(q23;q23)
  Malignant melanoma Skin
KIRREL/CD48
t(1;1)(q23;q23)
  Adenocarcinoma Stomach
NOS1AP/PBX1
t(1;1)(q23;q23)
  Adenocarcinoma Liver
PFDN2/APOA2
t(1;1)(q23;q23)
  Adenocarcinoma Uterus, corpus
PRCC/RRNAD1
t(1;1)(q23;q23)
  Adenocarcinoma Lung
PVRL4/PFDN2
t(1;1)(q23;q23)
  Squamous cell carcinoma Lung
UAP1/NOS1AP
t(1;1)(q23;q23)

Lai et al 2015, BMC Genomics
  Adenocarcinoma Prostate
NOS1AP/C1ORF226
t(1;1)(q23;q23)

McPherson et al 2011, PLoS Comput Biol
  Gonadal stromal cell tumors Ovary
PCP4L1/SDHC
t(1;1)(q23;q23)

Pintarelli et al 2016, Oncotarget
  Nonneoplastic epithelial disorder/lesion Lung
TSTD1/F11R
t(1;1)(q23;q23)

Seki et al 2017, Nat Genet
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
VANGL2/UFC1
t(1;1)(q23;q23)
T-Lineage

Shah et al 2013, BMC Genomics
  Astrocytoma, grade III-IV/Glioblastoma Brain
BCAN/NTRK1
t(1;1)(q23;q23)

Yoshihara et al 2015, Oncogene
  Adenocarcinoma Thyroid
SLAMF1/CD1A
t(1;1)(q23;q23)
  Adenocarcinoma Prostate
ETV3/MNDA
t(1;1)(q23;q23)
  Adenocarcinoma Ovary
IGSF9/SLAMF9
t(1;1)(q23;q23)
  Adenocarcinoma Lung
NOS1AP/ATF6
t(1;1)(q23;q23)
  Adenocarcinoma Lung
SLAMF1/CD1C
t(1;1)(q23;q23)
  Adenocarcinoma Lung
F11R/NOS1AP
t(1;1)(q23;q23)
  Adenocarcinoma Lung
ATF6/PCP4L1
t(1;1)(q23;q23)
  Adenocarcinoma Breast
ATF6/SH2D1B
t(1;1)(q23;q23)
  Adenocarcinoma Breast
UHMK1/PPOX
t(1;1)(q23;q23)
  Adenocarcinoma Breast
ARHGEF11/ETV3
t(1;1)(q23;q23)
  Adenocarcinoma Breast
IQGAP3/SH2D2A
t(1;1)(q23;q23)
  Adenocarcinoma Breast
FCGR2A/SPTA1
t(1;1)(q23;q23)
  Adenocarcinoma Breast
NCSTN/ATP1A4
t(1;1)(q23;q23)
  Adenocarcinoma Breast
PRCC/HAPLN2
t(1;1)(q23;q23)
  Adenocarcinoma Breast
IQGAP3/ETV3
t(1;1)(q23;q23)
  Adenocarcinoma Breast
USP21/PVRL4
t(1;1)(q23;q23)
  Transitional cell carcinoma Bladder
PCP4L1/NDUFS2
t(1;1)(q23;q23)